The ability of Smad7 to act as a transcription factor has been previously shown in prostatic cancer cells, where Smad7 can bind the regulatory regions and enhance the expression of c-Jun and Histone deacetylase 6, two tumor-promoting genes [18]. Here, JUN is linked to prostate cancer.